Posts with tag: travel
Honeywell (HON) Announces Separation Into Three Public Companies: Honeywell Automation, Honeywell Aerospace, and Advanced Materials
Published on: February 06, 2025, 03:02 PM UTC
Eli Lilly Q4 2024 earnings beat estimates, driven by strong GLP-1 drug sales, despite missing on expectations. Revenue increased 45% to $13.5 billion, and the company raised its 2025 guidance. Investors will focus on management's commentary on prescription volume and coverage dynamics for Mounjaro and Zepbound, as well as updates on orforglipron, a potential pill option for GLP-1 therapy.
Published on: February 06, 2025, 03:02 PM UTC
Insight Enterprises Inc. (NSIT) reported fourth-quarter earnings of $37 million, exceeding Wall Street expectations. Earnings per share were $2.66, adjusted for one-time gains and costs, while revenue reached $2.07 billion.
Published on: February 06, 2025, 02:07 PM UTC
Compare taxes: Sweden's pre-filled returns vs. the US's complex, 13-hour process. See why the US tax code is so complicated and how it could be simplified.
Published on: February 06, 2025, 02:03 PM UTC
Contact lens maker Bausch + Lomb will not be taken private after exploring a potential sale and other options to exit the eye-care company.
Published on: February 06, 2025, 01:09 PM UTC
Peloton's Q4 revenue beats estimates while sales decline year-on-year. The company's guidance for next quarter falls short, but EBITDA guidance exceeds expectations. Dive into our full research report for insights on Peloton's valuation, business qualities, and earnings performance.
Published on: February 06, 2025, 01:04 PM UTC
Honeywell to Split into Three: Automation, Aerospace, and Advanced Materials
Published on: February 06, 2025, 01:01 PM UTC
Cemex sees improving cement demand in the US, its largest market, after lower volumes dented sales in 2024. The company expects a boost in 2025 from transportation projects and manufacturing projects.
Published on: February 06, 2025, 01:00 PM UTC
Honeywell International plans to split into three independent companies, separating its aerospace division from its automation business and spinning off its advanced-materials arm.
Published on: February 06, 2025, 01:00 PM UTC
Haemonetics Corp. reported fiscal third-quarter net income of $37.5 million, or 74 cents per share. Adjusted earnings were $1.19 per share, meeting Wall Street expectations. Revenue was $348.5 million.
Published on: February 06, 2025, 12:07 PM UTC